AI Solutions Enhance Trial Efficiency and Quality
On April 7, 2026, in Durham, N.C., Fortrea, a global leader in clinical research, announced the launch of Fortrea Intelligent Technology (FIT), a comprehensive suite of AI-powered solutions designed to transform clinical trial operations. This innovative technology aims to streamline processes, enhance trial speed, and improve quality, predictability, and efficiency. Fortrea’s FIT is built upon their flagship Xcellerate® platform, which already provides near-real-time, role-based insights for sponsors and study teams.
According to Alejandro Martinez Galindo, Chief Information Officer, “We are at a remarkable moment in time, where the evolution of clinical trials is converging with unprecedented advancements in technology. Fortrea Intelligent Technology sits at this nexus.” The FIT suite integrates persona-driven, AI-powered solutions that automate workflows and streamline oversight, enabling faster and more predictable trials.
Key Features of FIT
FIT is organised into three key pillars: Lifecycle, Foresight, and Companion. The Lifecycle pillar accelerates trial processes by automating key steps from pre-award to final eTMF. Meanwhile, the Foresight pillar transforms data into actionable insights, facilitating faster decision-making and proactive risk mitigation through intuitive dashboards. These features help sponsors and sites progress clinical trials throughout each step of the clinical development journey.
The Companion pillar empowers study teams with AI-driven tools that enhance productivity and collaboration. These solutions support more efficient clinical trial operations across biopharma and biotech sectors, including clinical pharmacology and medical device development. Fortrea offers the FIT system in both full service and functional service models. Select components are available as software-as-a-service (SaaS), providing flexible deployment options for diverse customer needs.
Fortrea’s FIT also includes applications for biopharma and biotech customers, and it can be deployed to support clinical pharmacology, development, and medical device sectors. By leveraging decades of industry experience and feedback from sponsors and investigator sites, Fortrea is committed to delivering human-centred solutions that reduce trial risks and increase confidence.
Looking ahead, Fortrea plans to expand the FIT portfolio with additional solutions, aiming to further enhance the capabilities and efficiencies of clinical trial operations. These advancements are expected to continue to transform the landscape of clinical trials, providing even greater support for sponsors, sites, and study teams.
Last updated: 29 June 2026, 12:33 pm
